Cargando…

Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?

BACKGROUND: Cognitive complaints are one of the most frequent symptoms reported in post-acute sequelae of COVID-19 (PASC). The Montreal Cognitive Assessment (MoCA) has been used to estimate prevalence of cognitive impairment in many studies of PASC, and is commonly employed as a screening test in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lynch, Sean, Ferrando, Stephen J., Dornbush, Rhea, Shahar, Sivan, Smiley, Abbas, Klepacz, Lidia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359801/ https://www.ncbi.nlm.nih.gov/pubmed/35930974 http://dx.doi.org/10.1016/j.genhosppsych.2022.07.013

Ejemplares similares

(41) Screening for Brain Fog: Is the Montreal Cognitive Assessment an Effective Screening Tool for Neurocognitive complaints Post-COVID-19?
por: Lynch, Sean T., et al.
Publicado: (2022)

Frequency and Characteristics of Depression and Its Association with Diminished Quality of Life in a Cohort of Individuals with Post-Acute Sequelae of COVID-19
por: Shahar, Sivan, et al.
Publicado: (2023)

Impact of COVID-19 on employment: sociodemographic, medical, psychiatric and neuropsychological correlates
por: Thompson, Madison, et al.
Publicado: (2023)

Anxiety and posttraumatic stress in post-acute sequelae of COVID-19: prevalence, characteristics, comorbidity, and clinical correlates
por: Ferrando, Stephen J., et al.
Publicado: (2023)

Psychiatric emergencies during the height of the COVID-19 pandemic in the suburban New York City area
por: Ferrando, Stephen J., et al.
Publicado: (2021)

Neuropsychological, Medical, and Psychiatric Findings After Recovery From Acute COVID-19: A Cross-sectional Study
por: Ferrando, Stephen J., et al.
Publicado: (2022)

Characteristics of Calls to a COVID-19 Mental Health Hotline in the First Wave of the Pandemic in New York
por: Abdullah, Hussain, et al.
Publicado: (2021)

Olfactory Hallucinations in the Context of Coronavirus Disease 2019
por: Kumar, Parul, et al.
Publicado: (2021)

Post-traumatic stress disorder can be predicted in hospitalized blunt trauma patients using a simple screening tool
por: Rahmat, Saad, et al.
Publicado: (2021)

COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response?
por: Ferrando, Stephen J., et al.
Publicado: (2020)

Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
por: Bello-Lepe, Sebastian, et al.
Publicado: (2020)

Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
por: Raghunath, Sudha, et al.
Publicado: (2021)

Montreal cognitive assessment in primary sjogren’s syndrome: A brief screening tool
por: Kurtuluş, Fatma, et al.
Publicado: (2019)

Validity and reliability of two alternate versions of the Montreal Cognitive Assessment (Hong Kong version) for screening of Mild Neurocognitive Disorder
por: Wong, Adrian, et al.
Publicado: (2018)

Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex
por: Hugon, Jacques, et al.
Publicado: (2021)

Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose
por: Yeung, Pui Yu, et al.
Publicado: (2020)

The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus
por: Paez-Venegas, Nicolas, et al.
Publicado: (2019)

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains
por: Early, Macy L., et al.
Publicado: (2022)

Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old‐old
por: Chen, Matthew Zhixuan, et al.
Publicado: (2022)

Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue(®) to the Montreal Cognitive Assessment
por: Rose, Amanda F, et al.
Publicado: (2021)

Routine cognitive screening in older patients admitted to acute medicine: abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE
por: Pendlebury, S. T., et al.
Publicado: (2015)

Montreal Brain Injury Vision Screening Test for General Practitioners
por: Abbas Farishta, Reza, et al.
Publicado: (2022)

The Screening Accuracy of a Visually Based Montreal Cognitive Assessment Tool for Older Adult Hearing Aid Users
por: Utoomprurkporn, Nattawan, et al.
Publicado: (2021)

The Beijing version of the montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study
por: Yu, Jing, et al.
Publicado: (2012)

DEVELOPMENT OF A SWEDISH SHORT VERSION OF THE MONTREAL COGNITIVE ASSESSMENT FOR COGNITIVE SCREENING IN PATIENTS WITH STROKE
por: ABZHANDADZE, Tamar, et al.
Publicado: (2023)

Validation of the Argentine version of the Montreal Cognitive Assessment Test (MOCA): A screening tool for Mild Cognitive Impairment and Mild Dementia in Elderly
por: Serrano, Cecilia M., et al.
Publicado: (2020)

Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease
por: CHEN, Ling, et al.
Publicado: (2013)

Feasibility of Cognitive Functions Screened With the Montreal Cognitive Assessment in Determining ADL Dependence Early After Stroke
por: Abzhandadze, Tamar, et al.
Publicado: (2018)

Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Montreal Cognitive Assessment in Older Adults
por: Messinis, Lambros, et al.
Publicado: (2022)

Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment
por: Thomann, Alessandra E., et al.
Publicado: (2020)

Computerized screening tools for neurocognitive impairment in patients with HIV infection
por: Cercel, Ioana-Catrinel, et al.
Publicado: (2014)

Comparison of Oxford Cognitive Screen and Montreal Cognitive Assessment feasibility in the stroke unit setting. A pilot study
por: Brambilla, Michela, et al.
Publicado: (2021)

The Montreal Cognitive Assessment (MoCA) - A Sensitive Screening Instrument for Detecting Cognitive Impairment in Chronic Hemodialysis Patients
por: Tiffin-Richards, Frances E., et al.
Publicado: (2014)

Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version
por: Kaur, Darshpreet, et al.
Publicado: (2013)

When Did the Empathy Die?: Examining the Correlation Between Length of Medical Training and Level of Empathy
por: Dinoff, Adam, et al.
Publicado: (2023)

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature
por: Zipursky, Amy R., et al.
Publicado: (2013)

Development of TUA-WELLNESS screening tool for screening risk of mild cognitive impairment among community-dwelling older adults
por: Vanoh, Divya, et al.
Publicado: (2016)

Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening
por: Angermann, Susanne, et al.
Publicado: (2017)

Screening for cognitive impairment among patients with work-related stress complaints in Denmark: validation and evaluation of objective and self-report tools
por: Jensen, Johan Høy, et al.
Publicado: (2022)

Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms
por: Lee, Sun Hwa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lcnii13ugqfv5bd16kc4e2b2i1